Whistleblower charges drug company with deceptive practices

BMJ. 2003 Mar 22;326(7390):620. doi: 10.1136/bmj.326.7390.620.
No abstract available

Publication types

  • News

MeSH terms

  • Deception
  • Drug Industry / legislation & jurisprudence*
  • Humans
  • United States
  • Whistleblowing*